Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Author(s):
Marianna Fontana
,
Added:
17 hours ago
Video Series
Author(s):
Armin Arbab-Zadeh
,
Michelle Graham
,
Hector M Garcia-Garcia
,
et al
Added:
8 months ago
Author(s):
Harriette Van Spall
,
Michael Andrew Borger
Added:
8 months ago
ESC Congress 2025 - Dr Harriette Van Spall (McMaster University, Canada) sits down with Professor Michael Borger (University of Leipzig Heart Center, Germany), Co-Chair of the newly released 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.The new guidelines bring together the latest evidence and expert consensus on how to diagnose, evaluate, and treat patients with valvular…
View more
Author(s):
Giuseppe Ferrante
,
Brittany A Bacallao
,
Francesco Gioia
,
et al
Added:
1 year ago
Author(s):
Roland R Tilz
Added:
2 years ago
EHRA 24 - We are joined onsite by Dr Roland Tilz (University Heart Center, DE) to discuss the findings of the Style-AF study (NCT05563142).This prospective, randomized, controlled study aims to compare the safety and efficacy of the Perclose ProStyle suture-medicated closure device to manual compression for the treatment of hemostasis after single-shot-device pulmonary vein isolation (PVI). 125…
View more
Author(s):
María Iglesias Alonso
,
Jose Manuel Iglesias Sanmartin
Added:
1 month ago
Obesity Management and Cardiovascular Disease
Author(s):
Miao Gao
,
Tanjot Singh
,
Ramzi Ajjan
Added:
1 month ago
Review Article
ESC 25: SWEDEPAD 1 and 2
Author(s):
Marten Falkenberg
,
Joakim Nordanstig
Added:
8 months ago
Video
Author(s):
David J Cohen
Added:
6 months ago
TCT 2025 - The PREVUE-VALVE study finds an 8.2% prevalence of moderate or greater valvular heart disease amongst Americans age 65-85, increasing to 18.4% when participants with mild to moderate VHD were included.Dr David J. Cohen (Cardiovascular Research Foundation & St Francis Hospital, US) joins us to discuss findings from the PREVUE-VALVE study, examining age and sex-specific prevalence of…
View more
New Horizons in Cardio Kidney Disease
Author(s):
Muthiah Vaduganathan, Neha Pagidipati, Smeeta Sinha
Start date:
Jun 30, 2026
Broadcast